Excerpted and adapted from:
Xie D, Choi HK, Dalbeth N, et al. Gout and excess risk of severe SARS-CoV-2 infection among vaccinated individuals: A general population study. Arthritis Rheumatol.2023 Jan;75(1):122–123.
Excerpted and adapted from:
Xie D, Choi HK, Dalbeth N, et al. Gout and excess risk of severe SARS-CoV-2 infection among vaccinated individuals: A general population study. Arthritis Rheumatol.2023 Jan;75(1):122–123.
New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.
The Basic and Clinical Research Conference session on Rheumatology Complications of Emerging Viral Infections/SARS-CoV-2 presented findings from numerous studies that help explain some of the idiosyncrasies of COVID-19.
At a recent ACR town hall, panelists described immune responses and side effects of COVID-19 vaccination in patients with rheumatic disease, along with ways to leverage monoclonal antibody treatments, especially in light of virus variants.
Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…